首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6428篇
  免费   848篇
  国内免费   145篇
耳鼻咽喉   16篇
儿科学   190篇
妇产科学   196篇
基础医学   820篇
口腔科学   188篇
临床医学   679篇
内科学   1385篇
皮肤病学   35篇
神经病学   579篇
特种医学   184篇
外国民族医学   1篇
外科学   626篇
综合类   544篇
现状与发展   1篇
预防医学   728篇
眼科学   82篇
药学   546篇
  1篇
中国医学   108篇
肿瘤学   512篇
  2024年   62篇
  2023年   318篇
  2022年   495篇
  2021年   617篇
  2020年   412篇
  2019年   391篇
  2018年   287篇
  2017年   299篇
  2016年   262篇
  2015年   254篇
  2014年   384篇
  2013年   499篇
  2012年   270篇
  2011年   289篇
  2010年   229篇
  2009年   263篇
  2008年   233篇
  2007年   199篇
  2006年   182篇
  2005年   172篇
  2004年   133篇
  2003年   123篇
  2002年   106篇
  2001年   102篇
  2000年   91篇
  1999年   71篇
  1998年   76篇
  1997年   54篇
  1996年   59篇
  1995年   46篇
  1994年   40篇
  1993年   56篇
  1992年   44篇
  1991年   46篇
  1990年   32篇
  1989年   28篇
  1988年   40篇
  1987年   23篇
  1986年   23篇
  1985年   18篇
  1984年   27篇
  1983年   10篇
  1982年   19篇
  1981年   6篇
  1980年   10篇
  1979年   5篇
  1978年   2篇
  1977年   5篇
  1976年   2篇
  1975年   3篇
排序方式: 共有7421条查询结果,搜索用时 46 毫秒
41.
L. Haugaard  M. Iversen  R. Dahl 《Allergy》1997,52(10):999-1004
The influence of inhaled steroids and predictive factors on the response to bronchial allergen challenge (BCA) was evaluated in. 80 asthmatics allergic to Dermatophagoides pteronyssinus (Der p). All underwent BCA with Der p and measurement of early (EAR) and late asthmatic reaction (LAR). The cumulative dose of allergen producing 20% fall in FEV1, in the EAR (PD20) was calculated. Bronchial histamine provocation, conjunctival provocation test (CPT), and skin prick test with Der p extract were performed. Specific IgE to Der p in serum (RAST), blood eosinophil (EOS) count, serum eosinophil cationic protein, and eosinophil protein X were measured. Thirty patients (38%) were treated with inhaled steroids. All patients had at least a 20% fall in FEV1 in EAR. Some 42% of nonsteroid- and 33% of steroid-treated patients had LAR with fall in peak flow of at least 20%. For patients not treated with steroid, 35% of variation in PD20 was explained by RAST and histamine reactivity, and 53% of variation of observed PD20 could be predicted. The baseline FEV1, EOS, and EAR explained 28% of variation in LAR, and 28% of variation in observed LAR could be predicted. For patients treated with steroids, 38% of variation in PD20 was explained by EOS and histamine reactivity, and only 18% of variation of observed PD20 could be predicted. For patients treated with steroids, it was impossible to predict LAR. We conclude that to achieve a quantitative estimation of allergen-specific EAR and LAR, BCA cannot be replaced by the tests used in this study. Treatment with inhaled steroids modifies the response to BCA, making quantitative prediction of EAR less accurate and prediction of the magnitude of LAR impossible.  相似文献   
42.
SARS coronavirus induces apoptosis in Vero E6 cells   总被引:15,自引:0,他引:15  
Severe acute respiratory syndrome (SARS) is an emerging infectious disease. Its etiological agent has been convincingly identified as a new member of family Coronaviridae (SARS-CoV). It causes serious damage to the respiratory system yet the mechanism is not clear. Infection-induced apoptosis or necrosis is suspected but no direct evidence for this yet exists. To date, Vero E6 cells are the only cell line that could be used to replicate the virus with obvious CPE (cytopathic effect) in vitro. It is known for some viruses (including members of family Coronaviridae) that CPE can be caused either by virus-induced apoptosis (active death) or cell necrosis (passive death). In this study, we examined the apoptosis in the SARS-CoV infected Vero E6 cells. Indeed, the results do show that the CPE was induced by apoptosis rather than necrosis, shown by typical DNA fragmentation, through the existence of apoptotic bodies and swollen mitochondria. This observation has some implications for the SARS-CoV pathogenicity: SARS-CoV does induce apoptosis in cell cultures and might have the same effect in vivo, responsible for the severe damage of the respiratory system.  相似文献   
43.
Glioblastoma is an aggressive and fast-growing brain tumor with poor prognosis. Predicting the expected survival of patients with glioblastoma is a key task for efficient treatment and surgery planning. Survival predictions could be enhanced by means of a radiomic system. However, these systems demand high numbers of multicontrast images, the acquisitions of which are time consuming, giving rise to patient discomfort and low healthcare system efficiency. Synthetic MRI could favor deployment of radiomic systems in the clinic by allowing practitioners not only to reduce acquisition time, but also to retrospectively complete databases or to replace artifacted images. In this work we analyze the replacement of an actually acquired MR weighted image by a synthesized version to predict survival of glioblastoma patients with a radiomic system. Each synthesized version was realistically generated from two acquired images with a deep learning synthetic MRI approach based on a convolutional neural network. Specifically, two weighted images were considered for the replacement one at a time, a T2w and a FLAIR, which were synthesized from the pairs T1w and FLAIR, and T1w and T2w, respectively. Furthermore, a radiomic system for survival prediction, which can classify patients into two groups (survival >480 days and 480 days), was built. Results show that the radiomic system fed with the synthesized image achieves similar performance compared with using the acquired one, and better performance than a model that does not include this image. Hence, our results confirm that synthetic MRI does add to glioblastoma survival prediction within a radiomics-based approach.  相似文献   
44.
许多重要的细胞过程如信号转导、转运、细胞运动以及多数调节机制均由蛋白-蛋白之间的相可作用介导,蛋白质之间的相互作用在物理上是通过在两个相互作用蛋白之间形成接触面的短残基序列来实现。识别蛋白-蛋白相互作用位点,以及检测相互作用氨基酸残基之间的特异性与强度特异性,是一个具有重要应用前景的课题,它的应用范围从理性的药物设计到代谢和信号转导网络的分析。虽然有不少准确度不断提高的实验技术和计算方法来检测蛋白质之间的相互作用,但很少有方法能够精确地指出参与蛋白质相互作用的特定残基及其位置,而这些信息是将相互作用数据直接应用于药物开发所必需的。随着生物信息学和计算生物学的发展,通过研究已知蛋白-蛋白相互作用位点的这些不同特征.出现了一些利用序列与结构信息顶测蛋白-蛋白相互作用位点的计算方法。本文简要介绍了近年来在顶测蛋白-蛋白的相互作用位点方面取得一定进展的计算方法,包括基于基因组信息的计算方法、基于蛋白质初级序列的计算方法以及基于蛋白复合物结构信息的计算方法。虽然这些方法在过去儿年里取得了显著的进展,但是大多数在这方面的研究仍处于起步阶段.而现在数据库的不足和实验技术的缺陷对计算预测方法的进一步发展和公平性评价也存在着较大的影响,要提高蛋白-蛋白相巨作用位点预测的鲁棒性与可靠性,仍要有很多的工作要做。(发表在这里的是第一部分)  相似文献   
45.
The binding affinity between an antigenic peptide and its particular major histocompatibility complex (MHC) molecule seems to be largely determined by only a few residues. These residues have been called “anchors” because of their property of fitting into “pockets” inside the groove of the MHC molecule. To predict natural antigenic epitopes within a longer sequence, it therefore appears to be important to know the motif or pattern describing the anchors, i.e. the anchors amino acid residue preference and the distance between anchor residues. A large set of MHC class I-restricted peptides has been described. Peptide sequences vary in length and lack an obvious common sequence motif. For a list of peptides belonging to one type of MHC class I molecule, we describe a method to find the most prominent sequence motif with at least two anchor residues. Briefly, antigenic sequences are aligned, and two anchor positions are searched for, where all anchor residues share a high similarity. The alignments are scored according to the similarity of their anchor residues. We show that the motifs predicted for the MHC alleles A2.1, B27, Kb, Kd, Db are in substantial agreement with experimental data. We derive binding motifs for the MHC class I alleles HLA-A1, All, B8, B14, H-2Ld and for the MHC class II alleles I-Ab and I-As. In some cases, higher scores were obtained by allowing a slight variation in the number of residues between anchors. Therefore, we support the view that the length of epitopes belonging to a particular class I MHC is not uniform. This method can be used to predict the natural short epitope inside longer antigenic peptides and to predict the epitopes anchor residues. Anchor motifs can be used to search for antigenic regions in sequences of infectious viruses, bacteria and parasites.  相似文献   
46.
目的应用生物信息学方法预测B族链球菌C5a肽酶蛋白表位,结合基因工程手段进行表位重组、表达和免疫原性分析。方法用预测程序ProPred和ANTIGENIC预测B族链球菌C5a肽酶蛋白的表位,应用PCR技术扩增出编码该表位基因片段,克隆PCR产物构建重组质粒,测序验证。在大肠杆菌BL21(DE3)中诱导表达融合蛋白。表达的蛋白经质谱分析和Western blot鉴定。纯化该融合蛋白并免疫C57/BL小鼠,萃取GBS表面蛋白,双向琼脂扩散试验检测抗体水平。结果在SCPB中预测到1个既具有MHC结合肽特性又具有B细胞表位特征的肽段。重组和表达了这一肽段,质谱得出与SCPB蛋白的相似性分数为79,Western-blot证实能与抗SCPB的抗体反应,纯化后融合蛋白纯度〉90%。动物实验证实融合蛋白能产生特异性的抗GBS抗体。结论重组表位具有一定免疫原性。为相关蛋白的毒力机制研究和亚单位疫苗等方面的研究打下了良好的基础。  相似文献   
47.
A scoring system specific for day 3 embryos has not been extensively explored. Most IVF laboratories continue to grade embryos solely on the basis of cell number and percentage fragmentation as was traditionally done for day 2 embryos. Additional morphological features, some unique to day 3 embryos, may be useful in selecting embryos most likely to blastulate and implant. The objective of this study was to derive an embryo scoring system for day 3 transfers which is predictive of positive pregnancy outcomes. A total of 316 transferred embryos from 93 patients was recorded on videotape and evaluated. The following parameters were used to grade the embryos: cell number, fragmentation pattern (FP), cytoplasmic pitting, compaction, equal sized blastomeres, blastomere expansion and absence of vacuoles. The clinical pregnancy rate was 41.9%, with an implantation rate of 18% per embryo transferred. The mean number of embryos transferred per patient was 3.4. Three formulae were derived to score embryo quality in each transfer based on the average score of individual embryos transferred. In the first scoring system, cell number alone was used to predict pregnancy outcome. The second scoring system was based on blastomere number and the observed FP. The third scoring system utilized both blastomere number and FP but also combined this with five morphological criteria to yield a final day 3 embryo quality (D3EQ) score. We found the D3EQ score to be prognostic of pregnancy outcome. This study suggests that although cell number and FP are certainly predictors of positive pregnancy outcomes, additional parameters specific to day 3 embryos should be used to stratify a cohort of embryos further.  相似文献   
48.
The aim of this study was to examine the role of serum and follicular fluid pro-inflammatory cytokines and vascular endothelial growth factor (VEGF) in the prediction of ovarian hyperstimulation syndrome (OHSS). A total of 156 consecutive women undergoing in-vitro fertilization were recruited. The study group comprised 12 women who subsequently developed moderate (n = 7) or severe (n = 5) OHSS. The two control groups were comprised of a randomized selection of 12 high-risk and 12 low-risk women in whom OHSS did not develop. Serum was collected on days of human chorionic gonadotrophin, oocyte retrieval, and embryo transfer. Serum and follicular fluid concentrations of interleukin (IL)-6, IL-8, tumour necrosis factor-alpha (TNF-alpha), and VEGF were measured. Follicular fluid IL-6 concentrations at the time of oocyte retrieval and serum IL-8 concentrations at the time of embryo transfer were significantly higher in the OHSS compared to the two control groups (P = 0.026 and P = 0.017 respectively). Serum concentrations of TNF-alpha and VEGF showed no statistically significant difference between the OHSS group and the controls at any studied time point. This study suggests that follicular fluid IL-6 concentrations at the time of oocyte retrieval and serum IL-8 concentrations on the day of embryo transfer may serve as early predictors for this syndrome.  相似文献   
49.
50.
目的 构建HPI毒力岛缺失的EAggEC17-2突变株,初步研究EAggEC菌株携带的耶尔森菌HPI毒力岛合成铁载体Ybt的功能。方法以EAggEC17-2为出发菌株,irp8基因部分序列作为同源重组的一侧序列,irp5基因序列作为同源重组的另一侧序列,中间插入有氯霉素(Can)抗性基因(cat基因)标记。通过接合转移和同源重组,构建了缺失约24kb的HPI毒力岛功能核心区区域EAggEC17-2的仝岛缺失株EA85。应用流式细胞技术(FACS)检测指示菌株WA-CS irp1::KN(pC3G3.3N)荧光强度的变化情况,对EA85缺失株和出发菌株进行了合成Ybt的功能比较研究。结果成功构建了EAggEC17-2HPI全岛缺失株EA85。EAggEC17-2菌株具有表达Ybt的功能,而缺失株EA85丧失了合成Ybt的能力。结论EAggEC17-2HPI毒力岛的缺失,使Ybt的合成彻底阻断。EAggEC17-2具有的合成Ybt的功能是由其染色体携带的HPI毒力岛所决定的。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号